Display options
Cite
Levine AJ, Palomo M, Hinkin CH, et al. A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers. Neurobehav HIV Med. 2011;3:79-86doi: 10.2147/NBHIV.S22553.
Levine, A. J., Palomo, M., Hinkin, C. H., Valdes-Sueiras, M., Lopez, E., Mathisen, G., Donovan, S., & Singer, E. J. (2011). A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers. Neurobehavioral HIV medicine, 379-86. https://doi.org/10.2147/NBHIV.S22553
Levine, Andrew J, et al. "A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers." Neurobehavioral HIV medicine vol. 3 (2011): 79-86. doi: https://doi.org/10.2147/NBHIV.S22553
Levine AJ, Palomo M, Hinkin CH, Valdes-Sueiras M, Lopez E, Mathisen G, Donovan S, Singer EJ. A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers. Neurobehav HIV Med. 2011;3:79-86. doi: 10.2147/NBHIV.S22553. PMID: 26448691; PMCID: PMC4593057.
Copy Download .nbib Format: NLM
Share it on

Neurobehav HIV Med. 2011;3:79-86. doi: 10.2147/NBHIV.S22553.

A comparison of screening batteries in the detection of neurocognitive impairment in HIV-infected Spanish speakers.

Neurobehavioral HIV medicine

Andrew J Levine, Manuel Palomo, Charles H Hinkin, Miguel Valdes-Sueiras, Enrique Lopez, Glenn Mathisen, Suzanne Donovan, Elyse J Singer

Affiliations

  1. National Neurological AIDS Bank, Department of Neurology, David Geffen School of Medicine at UCLA.
  2. Veterans Affairs Greater Los Angeles Healthcare System ; Department of Psychiatry and Behavioral Sciences, David Geffen School of Medicine at UCLA.
  3. National Neurological AIDS Bank, Department of Neurology, David Geffen School of Medicine at UCLA ; Olive View-UCLA Medical Center, Sylmar, CA, USA.
  4. Department of Psychiatry and Behavioral Sciences, David Geffen School of Medicine at UCLA ; Department of Psychiatry and Behavioral Neuroscience, Cedars-Sinai Medical Center, Los Angeles.

PMID: 26448691 PMCID: PMC4593057 DOI: 10.2147/NBHIV.S22553

Abstract

BACKGROUND: A substantial number of Spanish-speaking individuals from Mexico and Central America are now living in the United States. These individuals are at heightened risk for HIV infection and, due to late diagnosis and limited resources, for HIV-associated neurocognitive disorders (HAND). Early detection is key, yet adequate methods for detecting HAND in Spanish speakers, especially in resource-poor areas, remains problematic. Therefore, it is necessary to identify accurate yet efficient neurocognitive screening tools that are appropriate for use in resource-limited AIDS clinics serving Spanish-speaking patients.

METHODS: Twenty-one Spanish-speaking, HIV-positive adults who migrated from Mexico or Central America underwent neuromedical and neurocognitive evaluation in Spanish. The concordance of three neurocognitive screening measures (the HIV Dementia Scale [HDS], the Mini-Mental State Examination [MMSE], and the NEUROPSI) with a comprehensive neuropsychological battery was examined. In addition, accuracy in detecting neurocognitive impairment using standard and alternative cutoff scores was examined.

RESULTS: The HDS and the NEUROPSI showed high correlation with the comprehensive neuropsychological battery. The HDS and the NEUROPSI also had the highest sensitivity (67% and 75%, respectively) and specificity (50% and 38%, respectively). Both measures also showed greater sensitivity than the MMSE to very mild forms of HAND.

CONCLUSION: In this small sample of HIV-positive Spanish speakers from Mexico and Central America living in the United States, the HDS and the NEUROPSI demonstrated reasonable accuracy in detecting neurocognitive impairment, while the MMSE demonstrated very poor accuracy. The HDS and the NEUROPSI were equally sensitive in detecting mild HAND. Continued test development is required to capture this disorder, especially in resource-limited settings.

Keywords: HIV Dementia Scale; HIV-associated neurocognitive disorders; Mini-Mental State Examination; NEUROPSI; Spanish speaking

References

  1. J Acquir Immune Defic Syndr. 2004 Nov 1;37 Suppl 4:S204-14 - PubMed
  2. Neuropsychol Rev. 2009 Jun;19(2):152-68 - PubMed
  3. Lancet. 1974 Sep 14;2(7881):605-9 - PubMed
  4. Clin Neuropsychol. 2009 Jul;23(5):761-79 - PubMed
  5. J Neurol Sci. 2007 Sep 15;260(1-2):11-5 - PubMed
  6. Neurology. 1996 Nov;47(5):1247-53 - PubMed
  7. J Neurovirol. 2003 Apr;9(2):205-21 - PubMed
  8. J Clin Exp Neuropsychol. 2008 Jan;30(1):83-90 - PubMed
  9. AIDS Behav. 2005 Jun;9(2):201-10 - PubMed
  10. J Community Health. 1997 Jun;22(3):185-98 - PubMed
  11. Arch Clin Neuropsychol. 2007 Mar;22(3):333-41 - PubMed
  12. Appl Neuropsychol. 2000;7(1):25-31 - PubMed
  13. Ann Neurol. 2010 Jun;67(6):699-714 - PubMed
  14. BMC Res Notes. 2010 Jan 29;3:28 - PubMed
  15. J Clin Exp Neuropsychol. 1990 Dec;12(6):963-78 - PubMed
  16. Clin Neuropsychol. 1999 Aug;13(3):348-58 - PubMed
  17. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Mar 1;8(3):273-8 - PubMed
  18. J Acquir Immune Defic Syndr. 2003 May 1;33(1):116-8 - PubMed
  19. J Psychiatr Res. 1975 Nov;12(3):189-98 - PubMed
  20. J Acquir Immune Defic Syndr. 2004 Nov 1;37 Suppl 4:S227-39 - PubMed
  21. Neuropsychol Rev. 2009 Jun;19(2):250-62 - PubMed
  22. J Int Neuropsychol Soc. 2009 May;15(3):438-50 - PubMed
  23. Semin Neurol. 2007 Feb;27(1):86-92 - PubMed
  24. Arch Clin Neuropsychol. 2007 Mar;22(3):319-25 - PubMed
  25. Clin Neuropsychol. 2001 May;15(2):228-34 - PubMed
  26. Neurology. 2010 Dec 7;75(23):2087-96 - PubMed
  27. Am J Public Health. 2001 Jun;91(6):927-32 - PubMed
  28. J Int Neuropsychol Soc. 1999 Jul;5(5):413-33 - PubMed
  29. J Clin Exp Neuropsychol. 1997 Aug;19(4):473-83 - PubMed
  30. AIDS Patient Care STDS. 2007 Dec;21(12):930-41 - PubMed
  31. J Neurovirol. 2006 Oct;12(5):356-64 - PubMed
  32. Neurology. 2007 Jan 30;68(5):324-5 - PubMed
  33. J Neurol Sci. 2008 Jun 15;269(1-2):62-4 - PubMed
  34. J Clin Exp Neuropsychol. 1997 Aug;19(4):615-22 - PubMed

Publication Types

Grant support